Latest News Release

Oncolytics Biotech Granted Ras Targeted Herpes Virus Patent

Oncolytics Biotech Announces 2003 Third Quarter Results

ONCOLYTICS BIOTECH AND THE U.S. NATIONAL CANCER INSTITUTE TO COLLABORATE ON MULTIPLE CLINICAL TRIALS WITH REOLYSIN®

Oncolytics Biotech to Present at Rodman & Renshaw Techvest Healthcare Conference

ONCOLYTICS BIOTECH CLOSES $6 MILLION BOUGHT DEAL FINANCING

ONCOLYTICS BIOTECH ENTERS INTO A BOUGHT DEAL FINANCING AGREEMENT FOR $5 MILLION

Oncolytics’ Research Collaborators Publish Animal Data on Oncolytic Adenoviruses

Oncolytics Biotech to Present at the UBS Warburg Global Life Sciences Conference


Year

Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More

Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More

View all news articles

Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More

Exploring REOLYSIN<sup>®</sup>’s Objective Response Rate in Females with Colorectal Cancer thumbail
View all blog posts

LATEST TWEETS

Follow us on Twitter